Compare American Superconductor Corporation (AMSC) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Superconductor Corporation vs Novartis AG — how do they compare? American Superconductor Corporation trades at $32.79 (market cap $1.56B), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 189.3× American Superconductor Corporation's market cap, and Novartis AG pays a 3.07% dividend while American Superconductor Corporation pays none. Which is the better fit depends on your goals.
| AMSC | NVS | |
|---|---|---|
Market Cap | $1.56B | $295.37B |
Sector | Technology | Health |
52-Week High | $66.68 | $168.62 |
52-Week Low | $25.95 | $119.31 |
Enterprise Value | $1.42B | $336.69B |
Dividend Yield | — | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Superconductor Corporation
AMSC provides energy technology solutions for smarter and cleaner power grids. It offers wind turbine electronic controls and advanced grid systems that enhance the reliability and efficiency of renewable energy networks.
Read more on AMSC →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
